Brandywine Global Investment Management, LLC Theravance Biopharma, Inc. Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.39 - $10.22 $29,792 - $36,291	-3,551 Reduced 3.67%	93,249 $946,000
Q2 2022 Aug 11, 2022	SELL	$8.41 - $10.34 $120,263 - $147,862	-14,300 Reduced 12.87%	96,800 $877,000
Q4 2021 Feb 11, 2022	BUY	$7.42 - $11.05 $824,362 - $1.23 Million	111,100 New	111,100 $1.23 Million

Others Institutions Holding TBPH

# of Institutions

124

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.6 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.8 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.3 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.4 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.6 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $643M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account